Prolacta Bioscience Home Page
Why Choose Prolacta?
We are making the difference in the lives of critically ill and premature infants.

Prolacta is the pioneer in human milk-based nutritional products for critically ill and premature infants in the neonatal intensive care unit (NICU). Prolacta believes that there is no adequate replacement for human breast milk and, as such, we believe infant nutritional products should be human milk-based. As a scientifically driven company committed to improving premature infant nutrition, we are using human milk to change the standard of care in the NICU. Read more »

PremieLact™ is ready-to-feed, pasteurized human milk for trophic feeds. When mother’s milk is unavailable, PremieLact may be used as the initial feeding of a 100% human milk diet. PremieLact provides approximately 0.7 kcal and 0.012 grams of protein per mL and contains no added minerals.

View PremieLact Spec Sheet (PDF)  View PremieLact Spec Sheet

Press Release - Jan. 19, 2010
Groundbreaking study demonstrates benefits of exclusively human milk-based diet for very low-birth-weight preterm infants in neonatal intensive care units.

View Press Release  View Press Release

NEO Conference Date: February 11-14, 2010
Location: Orlando, FL
Website: www.neoconference.com



Randomized Clinical Trial
"A Randomized Controlled Trial of Human versus Bovine-Based Human Milk Fortifiers in Extremely Preterm Infants"